Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells
Abstract Cisplatin is one of the most efficacious antimitotic drugs used in the treatment of a range of malignant tumors. However, treatment failures are common due to the development of chemoresistance. In addition to its telomere maintenance function, telomerase plays a pro-survival role, inducing...
Guardado en:
Autores principales: | Zhengpei Zhang, Ling Yu, Guo Dai, Kezhou Xia, Gaiwei Liu, Qi Song, Chunjie Tao, Tian Gao, Weichun Guo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b900072c2a1a4c12a1d73abcb8c2bbea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Telomerase reverse transcriptase synergizes with calorie restriction to increase health span and extend mouse longevity.
por: Elsa Vera, et al.
Publicado: (2013) -
The GG genotype of telomerase reverse transcriptase at genetic locus rs2736100 is associated with human atherosclerosis risk in the Han Chinese population.
por: Lei Feng, et al.
Publicado: (2014) -
Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer
por: Zhang Q, et al.
Publicado: (2020) -
A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants
por: Mariann Unhjem Wiik, et al.
Publicado: (2021) -
Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
por: Miguel Angel Merlos Rodrigo, et al.
Publicado: (2021)